JustAnswer Tirzepatide Review: The Annual-Plan Price and Refund Limits

JustAnswer’s weight-loss product page identifies compounded tirzepatide and advertises $195.82 per month with purchase of an annual plan. That qualification is central to the comparison: it is not a verified month-to-month price. The inspected page does not establish the exact amount collected up front, its rounding, or the financial treatment of unused months.¹

The page says a medical provider evaluates eligibility and monitors treatment, with medication supplied only when clinically appropriate. It also warns that the compounded product is not FDA-approved and that website images do not establish the appearance or labeling of the preparation a patient receives. The product image mentions B12; have the prescriber and pharmacy confirm the actual ingredients rather than treating the image as the final prescription.¹

Before committing to the annual plan

Request a written order showing the medication, dose-specific supply, total annual obligation, installments if any, renewal date and the circumstances that stop future charges. An annual-plan monthly equivalent should be compared with another program’s annual total, not a flexible monthly refill without considering the longer obligation.

Also ask who provides the clinical care and which pharmacy dispenses your prescription. The product page names the service but did not establish the individual clinician, pharmacy assignment or guaranteed response time for your state. A prescription and a particular treatment are not guaranteed by starting the assessment.¹

Prescription sales become final early

The linked JustAnswer Pharmacy return policy says prescription sales are final once payment has been charged and the package has been handed to the carrier. It directs patients to cancel a subscription or change order details through the account before shipment. Unopened over-the-counter products have a separate possible return period; that is not a prescription medication return promise.²

For an annual purchase, ask how this shipment-based rule interacts with future unsent supplies and whether any provider or service fee is retained if treatment cannot continue. The public policy reviewed here does not resolve those questions. Lost or damaged medication should be reported to support; do not interpret cancellation of future deliveries as a refund of prior medication.

Clarify storage with the actual pharmacy

The general refund page says the pharmacy does not currently ship refrigerated products and suggests transit delays will not affect them. That wording does not independently verify the stability of this specific compounded injection or establish that its storage instructions match other tirzepatide products. Obtain preparation-specific shipping and storage guidance and a replacement process from the dispensing pharmacist.²

The main purchase questions are financial: the annual commitment behind the monthly headline, the rules for unused supplies, and the pharmacy-specific details a general return page cannot answer. Trial-style weight-loss percentages on the product page should not be treated as demonstrated results for this compounded formulation or for an individual patient.